RADX
RADIOPHARM SP ADR (RADX)
NASDAQ
$4.44+$0.05 (+1.26%)
Price as of Jun 23, 2026 7:44 PM EDT
  • $34.0M
    Market Cap
  • -1.82%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2025
Income Statement
Total Operating Revenue
3.6M
N/A
Cost of Revenue
3.6M
N/A
Gross Profit
39,276
N/A
Sales and Marketing Expense
N/A
N/A
Research and Development Expense
-27.5M
N/A
Depreciation and Amortization Expense
2.6M
N/A
Total Operating Expenses
14.6M
N/A
Operating Profit
-38.2M
N/A
Interest Income
N/A
N/A
Interest Expense
N/A
N/A
Interest Income and Expense and Net
0
N/A
Total Nonoperating Income and Expense
10.3M
N/A
Income before Taxes
-38.3M
N/A
Income Taxes
103,292
N/A
Extraordinary Items
N/A
N/A
Net Income
-38.3M
N/A
Net Income from Continuing Operations Applicable to Common
-38.3M
N/A
Basic EPS and Net Income
-1.76
N/A
Diluted EPS and Net Income
-1.76
N/A
Basic Weighted Average Shares
2.1B
N/A
Diluted Weighted Average Shares
2.1B
N/A
Balance Sheet
Cash and Cash Equivalents
29.1M
N/A
Short-Term Investments
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
29.1M
N/A
Total Current Assets
39.9M
N/A
Accumulated Depreciation
N/A
N/A
Property and Plant and Equipment and Net
53,466
N/A
Total Long-Term Assets
46.6M
N/A
Total Assets
86.5M
N/A
Income Taxes Payable
N/A
N/A
Total Short-Term Debt
N/A
N/A
Total Current Liabilities
14.9M
N/A
Total Long-Term Debt
N/A
N/A
Total Long-Term Liabilities
28.7M
N/A
Total Liabilities
43.6M
N/A
Retained Earnings
-154.7M
N/A
Total Stockholders Equity
42.9M
N/A
Total Shares Outstanding
N/A
N/A
Cash Flow
Cash from Operating Activities
-36.6M
N/A
Capital Expenditures
N/A
N/A
Cash from Investing Activities
1.8M
N/A
Dividends Paid
N/A
N/A
Cash from Financing Activities
45.4M
N/A
Financials Ratio
Gross Margin
N/A
N/A
Operating Margin
N/A
N/A
Return on Assets
N/A
N/A
Return on Equity
N/A
N/A
Revenue Growth
N/A
N/A
Current Ratio
N/A
N/A
Cash Ratio
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow